ROCHE DIAGNOSTICS BELGIUM
ActiveROCHE DIAGNOSTICS BELGIUM has been active since 1958 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €36.17M and a net result of €1.21M. Equity is growing by ~11.1% per year across the filed fiscal years. Its solvency ranks better than 62% of 4839 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
72
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability69=
Solvency82▲+2
Growth64=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2M at 30 days acceptable
Liquidity ample (current ratio 1.6 against 1.41 in 2024; short-term debt: 38.2% and cash: 0% of total assets), and 43.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
56.5%
Return on assets
1.9%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-06-2026, 52 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
52 d early
2024
44 d early
2023
2 d early
2022
31 d early
2021
29 d late
2020
39 d early
2019
50 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
18-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€131.20M▲ 1.3%
2024 · €129.58M
2018: €118.18M
2019: €121.50M
2020: €130.87M
2021: €156.16M
2022: €133.32M
2023: €129.82M
2024: €129.58M
2018 → 2025
EBIT margin
2.8%▼ 0.7pp
2024 · 3.4%
2018: 2.4%
2019: 3.6%
2020: 4.7%
2021: 3.8%
2022: 4.5%
2023: 5.2%
2024: 3.4%
2018 → 2025
Net result
€1.21M▼ 38.7%
2024 · €1.98M
2018: €971k
2019: €2.16M
2020: €3.74M
2021: €2.98M
2022: €3.86M
2023: €3.46M
2024: €1.98M
2018 → 2025
Working capital
€14.70M▲ 38.6%
2024 · €10.61M
2018: €-2.63M
2019: €-1.15M
2020: €3.59M
2021: €3.94M
2022: €10.26M
2023: €11.51M
2024: €10.61M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€156.16M-€133.32M▼ 14.6%€129.82M▼ 2.6%€129.58M▼ 0.2%€131.20M▲ 1.3%
Equity€25.65M-€29.51M▲ 15.1%€32.97M▲ 11.7%€34.95M▲ 6.0%€36.17M▲ 3.5%
Operating result€5.90M-€5.97M▲ 1.2%€6.69M▲ 12.1%€4.45M▼ 33.6%€3.62M▼ 18.6%
Net result€2.98M-€3.86M▲ 29.6%€3.46M▼ 10.3%€1.98M▼ 42.7%€1.21M▼ 38.7%
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 19% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €64.01M
Fixed assets
€24.85M▼ 6.7%
Current assets
€39.16M▲ 7.3%
Equity and liabilities €64.01M
Equity
€36.17M▲ 3.5%
Provisions
€1.33M▼ 5.2%
Debt
€26.51M▼ 1.0%
The debt ratio falls from 42.4% to 41.4%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€14.55M▲
2024 · €13.52M
Cash flow
€12.15M▲
2024 · €11.06M
Solvency
56.5%▲
2024 · 55.4%
Current ratio
1.60▲
2024 · 1.41
Quick ratio
1.25▲
2024 · 1.16
Debt / equity
0.73▼
2024 · 0.77
ROE
3.4%▼
2024 · 5.7%
ROA
1.9%▼
2024 · 3.1%
Interest coverage
105.38▼
2024 · 152.78
Debt
€26.51M▼
2024 · €26.78M
Debt ≤ 1 year
€24.46M▼
2024 · €25.90M
Income taxes
€1.48M▼
2024 · €1.63M
Staff costs
€27.15M▼
2024 · €28.09M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€63.13M€64.01M▲
Fixed assets21/28€26.63M€24.85M▼
Tangible fixed assets22/27€26.63M€24.84M▼
Plant, machinery and equipment23€1.55M€705k▼
Furniture and vehicles24€343k€293k▼
Other tangible fixed assets26€24.73M€23.85M▼
Financial fixed assets28-€3k
Other financial fixed assets284/8-€3k
Amounts receivable and cash guarantees285/8-€3k
Current assets29/58€36.51M€39.16M▲
Amounts receivable after more than one year29€1.68M-
Trade receivables290€1.68M-
Stocks and contracts in progress3€6.34M€8.56M▲
Stocks30/36€6.34M€8.56M▲
Goods purchased for resale34€6.34M€8.56M▲
Amounts receivable within one year40/41€28.41M€30.32M▲
Trade receivables40€26.76M€29.62M▲
Other amounts receivable41€1.65M€707k▼
Cash at bank and in hand54/58€0€0=
Deferred charges and accrued income490/1€78k€281k▲
Equity and liabilities
Total equity and liabilities10/49€63.13M€64.01M▲
Equity10/15€34.95M€36.17M▲
Contributions10/11€3.75M€3.75M=
Capital10€3.75M€3.75M=
Issued capital100€3.75M€3.75M=
Reserves13€31.20M€32.42M▲
Non-distributable reserves130/1€397k€397k=
Legal reserve130€375k€375k=
Other1319€22k€22k=
Tax-exempt reserves132€107k€107k=
Distributable reserves133€30.70M€31.91M▲
Profit (loss) carried forward14€642€335▼
Provisions and deferred taxes16€1.40M€1.33M▼
Provisions for liabilities and charges160/5€1.40M€1.33M▼
Other liabilities and charges164/5€1.40M€1.33M▼
Amounts payable17/49€26.78M€26.51M▼
Amounts payable within one year42/48€25.90M€24.46M▼
Financial debts43€6.87M€5.97M▼
Other loans439€6.87M€5.97M▼
Trade debts44€10.35M€11.93M▲
Suppliers440/4€10.35M€11.93M▲
Taxes, remuneration and social security45€8.69M€6.56M▼
Taxes450/3€2.49M€2.33M▼
Remuneration and social security454/9€6.19M€4.23M▼
Accrued charges and deferred income492/3€876k€2.06M▲
Income statement
Code20242025
Operating income70/76A€131.35M€133.37M▲
Turnover70€129.58M€131.20M▲
Other operating income74€1.77M€2.09M▲
Non-recurring operating income76A-€76k
Operating charges60/66A€126.91M€129.75M▲
Goods for resale, raw materials and consumables60€74.88M€77.30M▲
Purchases600/8€76.24M€79.33M▲
Change in stocks: decrease (increase)609€-1.36M€-2.03M▼
Services and other goods61€13.99M€13.21M▼
Remuneration, social security and pensions62€28.09M€27.15M▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9.08M€10.93M▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€631k€-167k▼
Provisions for liabilities and charges: additions (uses and reversals)635/8€-68k€-73k▼
Other operating charges640/8€314k€1.40M▲
Operating profit (loss)9901€4.45M€3.62M▼
Financial income75/76B€107k€11k▼
Recurring financial income75€107k€11k▼
Income from current assets751€98k€5k▼
Other financial income752/9€9k€6k▼
Financial charges65/66B€939k€936k▼
Recurring financial charges65€939k€936k▼
Debt charges650€89k€138k▲
Other financial charges652/9€851k€798k▼
Profit (loss) for the period before taxes9903€3.61M€2.69M▼
Income taxes67/77€1.63M€1.48M▼
Taxes670/3€1.63M€1.48M▼
Profit (loss) for the period9904€1.98M€1.21M▼
Profit (loss) for the period to be appropriated9905€1.98M€1.21M▼
Appropriation of the result
Profit (loss) to be appropriated9906€1.99M€1.22M▼
Profit (loss) brought forward from the previous period14P€4k€642▼
Transfer to equity691/2€1.99M€1.22M▼
To other reserves6921€1.99M€1.22M▼
Social balance
Average headcount (FTE)9087184.2187.3▲
The notes to these accounts (61 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
State Gazette act
Resignations & appointmentsBoard meeting · General meeting · Director resignation36 facts ▸
State Gazette act
Resignations & appointments
Board meeting · General meeting · Director resignation36 facts ▸
- Board meeting, 2026-05-21
- General meeting, 2026-06-04
- General meeting, 2026-06-15
- Director resignation, Bernard Colombo (bestuurder)
- Director appointment, Esther de Rooij (bestuurder)
- Mandate compensation, Esther de Rooij
- Director resignation, Maria Johanna Borst (bestuurder)
- Director appointment, Silvia Barceleiro (bestuurder)
- Mandate compensation, Silvia Barceleiro
- Power of attorney, Joris Beke Smets
- Power of attorney, Federica MENEGHESSO
- Power of attorney, Julie PIESSEVAUX
- +24 further facts in this act
09-06
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
17-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
29-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
30-06
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial
Highest result since 2018net €3.86M ▲29.6%
Net result €3.86M, the highest in the series.
29-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 29 days late
2021
31-12
Financial
Equity above €25MEq €25.65M ▲13.1%
4 profitable years in a row build equity to €25.65M.
22-06
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
11-06
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
08-05
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
23-05
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
11-05
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
30 directors, no change since 2026
Silvia Barceleiro
CurrentDirector · since 01-05-2026
Esther de Rooij
CurrentDirector · since 31-03-2026
01-05-2026
Silvia Barceleiro: Appointed as Director
01-05-2026
Maria Johanna Borst: Resigned as Director
31-03-2026
Esther de Rooij: Appointed as Director
31-03-2026
Bernard Colombo: Resigned as Director
27-03-2024
Annelies VAN BUYTEN: Resigned as Director
27-03-2024
Joris BEKE SMETS: Resigned as Director
01-07-2022
Carsten Amt: Resigned as Director
01-07-2022
Harald Borrmann: Resigned as Director
01-03-2022
Brigitte Nolet: Resigned as Director
15-11-2021
Lutz von Peter: Resigned as Managing director
10-11-2021
Anna-Maria Heuchel-Reinig: Resigned as Director
10-11-2021
Anna-Maria Heuchel-Reinig: Resigned as Managing director
01-01-2020
Dirk Uebelhör: Resigned as Director
01-11-2019
Samuel Vynck: Resigned as Director
07-06-2019
MICHAEL HEUER: Resigned as Director
06-02-2019
PRIYA RATNAM: Resigned as Director
01-12-2018
PRIYA RATNAM: Resigned as Director
01-07-2018
Erik Möckl: Resigned as Managing director
01-07-2018
Filip Colpaert: Resigned as Director
04-06-2018
Veerle Vermeulen: Resigned as Director
01-04-2018
Klaas Gutschoven: Resigned as Director
01-01-2018
Sabrina Schilling: Resigned as Director
01-04-2017
Dr Uta-Maria Ohndorf: Resigned as Managing director
17-03-2016
Richard Erwin: Resigned as Director
+ 9 not shown in this overview
Location & real-estate footprint
Registered office, Machelen (Brab.) · 1 establishment unit since 1958
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Berkenlaan 8A1831 Machelen (Brab.)Ground area
9,322 m²
Building footprint
1,390 m²
Volume, LiDAR
29,238 m³
Parcel 23015B0120/00E000, Flanders · tallest building 26.6 m, ±7 floors. Linked by address, not a title deed.
1 establishment unit
Berkenlaan 8A, 1831 Machelen (Brab.)
since 19582.005.770.255
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23015B0120/00E000 | Flanders | 9,322 m² | 1 · 1,390 m² | 26.6 m · 7 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Statutory auditor
1 auditor| C.B.V.A. Klynveld Peat Marwick Goerdeler, Bedrijfsrevisoren Statutory auditor · represented by Patrick Simons | - → 22-12-2017 |
Public money · subsidies and aid
Flemish government
2023 to 2024 · 2 entries · 2,811 EUR awarded · 2,811 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2024 | 1 | 1,448 EUR | 1,448 EUR |
| 2023 | 1 | 1,363 EUR | 1,363 EUR |
Schemes
Vlaams opleidingsverlof (VOV)
European Union, budget
2021 · 1 entry · 1,547,615 EUR in total| Year | Entries | awarded |
|---|---|---|
| 2021 | 1 | 1,547,615 EUR |
Projects
PROCUREMENT OF RAPID ANTIGENE TESTS FOR DIAGNOSTIC OF COVID-19
Recognitions · licences · registrations
Legal Entity Identifier
8945001XLCJ8KUOJ8Y21
Similar companies · same sector, comparable size
ABC DENTAL AND PHARMACEUTICAL CONSULTANCY
BE 0442.286.247
Nazareth-De Pinte · Eq €35.94M
GILEAD SCIENCES BELGIUM
BE 0882.565.584
Machelen (Brab.) · Eq €35.70M
ZIMMER BIOMET
BE 0474.708.991
Machelen (Brab.) · Eq €36.99M
Viatris Healthcare
BE 0403.048.064
Hoeilaart · Eq €37.94M
SYLPHAR
BE 0892.362.188
Sint-Martens-Latem · Eq €34.18M
Of 1,897 companies in sector 46460 we hold annual accounts for 1,116. 228 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded07-11-1958
Fiscal year end31-12
Activities, NACEBEL
46460Wholesale of pharmaceutical and medical goods
Sources
Crossroads Bank for EnterprisesNational Bank · 49 filingsAddress and cadastre registers
Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.